Soros Fund Management’s Gilead Sciences GILD Stock Holding History

Soros Fund Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,600	Closed	-$331K	–	196
2016 Q1	$331K	Buy	+3,600	New	+$325K	0.01%	194
2014 Q2	–	Sell	-50,000	Closed	-$3.54M	–	395
2014 Q1	$3.54M	Buy	+50,000	New	+$3.92M	0.04%	211
2013 Q4	–	Sell	-25,000	Closed	-$1.57M	–	259
2013 Q3	$1.57M	Sell	25,000 -100,000	-80%	-$5.98M	0.02%	203
2013 Q2	$6.4M	Buy	+125,000	New	+$6.52M	0.07%	143

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Soros Fund Management's GILD Position: Q2 2016 in Review

Soros Fund Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 3,600 shares — an estimated $331K sold.

Soros Fund Management first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $6.4M in Q2 2013. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Soros Fund Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
Soros Fund Management sold 3,600 Gilead Sciences shares in Q2 2016, an estimated $331K.
Soros Fund Management first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
Soros Fund Management's Gilead Sciences position peaked at $6.4M in Q2 2013.
1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.